Sort
172,184 grants matching “inflammation”
Age related determinants of HAND: A 12 year follow-up of CHARTER participants
$1,585,664Robert Kernachan Heaton · University Of California, San Diego · R01 · FY2015 · MH
Interrupting the Vicious Cycle of Obesity and Metabolic Syndrome
$1,585,560Jacob E Friedman · University Of Colorado Denver · R24 · FY2016 · DK
ROLE OF INFLAMMATION IN PULMONARY INJURY
$1,585,443University Of Virginia Charlottesville · P01 · FY2005 · HL
Integrative Molecular Epidemiology of Human Cancer
$1,585,226Curtis Harris · Division Of Basic Sciences - Nci · ZIA · FY2015 · CA
Biomarkers in Cancer Diagnosis,Prognosis, and Therapeutic Outcome
$1,585,226Curtis Harris · Division Of Basic Sciences - Nci · ZIA · FY2015 · CA
Novel Mechanisms Regulating the Adipocyte-Brain Hepatocyte Axis
$1,585,000Philipp E Scherer · Ut Southwestern Medical Center · P01 · FY2010 · DK
Host innate immune-microbial interactions and intestinal inflammation
$1,584,843Ryan Balfour Sartor · Univ Of North Carolina Chapel Hill · P01 · FY2017 · DK
Characterization Of Novel Chemokine Receptors In Lymphocytes
$1,584,105Joshua M Farber · National Institute Of Allergy And Infectious Diseases · ZIA · FY2011 · AI
Glucagon-Like Peptide-1 Receptor Agonist Treatment in Adult, Obesity-Related, Symptomatic Asthma
$1,583,667Katherine N Cahill · Vanderbilt University Medical Center · U01 · FY2024 · AI
Glucagon-Like Peptide-1 Receptor Agonist Treatment in Adult, Obesity-Related, Symptomatic Asthma
$1,583,667Katherine N Cahill · Vanderbilt University Medical Center · U01 · FY2022 · AI
Glucagon-Like Peptide-1 Receptor Agonist Treatment in Adult, Obesity-Related, Symptomatic Asthma
$1,583,667Katherine N Cahill · Vanderbilt University Medical Center · U01 · FY2025 · AI
Glucagon-Like Peptide-1 Receptor Agonist Treatment in Adult, Obesity-Related, Symptomatic Asthma
$1,583,667Katherine N Cahill · Vanderbilt University Medical Center · U01 · FY2021 · AI
Glucagon-Like Peptide-1 Receptor Agonist Treatment in Adult, Obesity-Related, Symptomatic Asthma
$1,583,667Katherine N Cahill · Vanderbilt University Medical Center · U01 · FY2023 · AI
Comparative Biomedical Scientist Training Program
$1,583,589Robert Simpson · Division Of Basic Sciences - Nci · ZIG · FY2019 · CA
BARRIER FUNCTION OF THE GI TRACT IN HEALTH AND DISEASE
$1,583,498Massachusetts General Hospital · P01 · FY2002 · DK
Regulation of Flt 1 Splicing by Fibronectin and Integrin Signaling During Aging
$1,583,383Patrick Andries Murphy · University Of Connecticut Sch Of Med/Dnt · RF1 · FY2023 · NS
BARRIER FUNCTION OF THE GI TRACT IN HEALTH AND DISEASE
$1,583,205Massachusetts General Hospital · P01 · FY2000 · DK
Sirtuins and nuclear receptors in aging and age-associated diseases
$1,583,065Xiaoling Li · National Institute Of Environmental Health Sciences · ZIA · FY2009 · ES
Genetic Analysis of Complex Inflammatory Disorders
$1,583,024Daniel Kastner · National Human Genome Research Institute · ZIA · FY2024 · HG
Leveraging an ongoing longitudinal study of influenza vaccination to define immune signatures of response and risk of infection in older adults >75
$1,583,019Sean X Leng · Johns Hopkins University · U01 · FY2025 · AI
Targeting Inflammation in Type 2 Diabetes: Clinical Trial Using Salsalate
$1,582,740Steven E Shoelson · Joslin Diabetes Center · U01 · FY2008 · DK
Exploring the impact of inflammaging on immune function during M. tb infection
$1,582,677Joanne Turner · Ohio State University · P01 · FY2017 · AG
Protein-glycan Interactions in the Vascular System
$1,582,458Rodger Paul McEver · Oklahoma Medical Research Foundation · P01 · FY2008 · HL
Beryllium: Exposure Immune and Genetic Mechanisms
$1,582,314Lee S Newman · University Of Colorado Denver · P01 · FY2012 · ES
Multi-functional anti-thrombotic therapy for coronary microvascular obstruction
$1,582,022Ridong Chen · Apt Therapeutics, Inc. · R44 · FY2023 · HL